<DOC>
	<DOCNO>NCT01867645</DOCNO>
	<brief_summary>Critical illness polyneuropathy and/or myopathy ( CIPNM ) severe complication critical illness . Retrospective data suggest early application IgM-enriched intravenous immunoglobulin ( IVIG ) may prevent mitigate CIPNM . Therefore , primary objective ass effect early IgM-enriched IVIG versus placebo mitigate CIPNM prospective setting .</brief_summary>
	<brief_title>The Impact IVIG Treatment Critical Illness Polyneuropathy and/or Myopathy Patients With MOF SIRS/Sepsis</brief_title>
	<detailed_description>Background : Critical illness polyneuropathy and/or myopathy ( CIPNM ) severe complication critical illness . Retrospective data suggest early application IgM-enriched intravenous immunoglobulin ( IVIG ) may prevent mitigate CIPNM . Therefore , primary objective ass effect early IgM-enriched IVIG versus placebo mitigate CIPNM prospective setting . Design : Prospective , randomize , double-blinded placebo-controlled trial Setting : Eight-bed medical ICU university hospital . Participants : Critically ill patient screened eligibility define multiple organ failure ( MOF ) SIRS/sepsis . Patients fulfil criterion assess neurologist clinical sign CIPNM . Critically ill patient multiple organ failure ( MOF ) , SIRS/sepsis , early clinical sign CIPNM randomize .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Critically ill patient failure least 2 organ system diagnose SIRS sepsis fulfil follow inclusion criterion include study . 1 . Age Range : 18 80 year 2. write information consent early possible 3 . Male female patient 4 . Clinical sign incipient CIPNM : decreased tendon reflex compare admission examination ICU weakness responsive cooperative patient compare admission examination ICU sign incipient muscular atrophy compare admission examination ICU Organ failure : Patients meet least two follow 5 criterion : cardiovascular system dysfunction : arterial systolic blood pressure &lt; 90mm Hg , mean arterial pressure &lt; 70mm Hg least one hour despite adequate fluid resuscitation , adequate intravascular volume status use vasopressor attempt maintain systolic blood pressure &gt; 90mm Hg mean arterial pressure &gt; 70mm Hg . kidney dysfunction : Urine output &lt; 0,5ml/kg body weight/ hour 1 hour , despite adequate fluid resuscitation respiratory system dysfunction : Ratio PaO2 FiO2 &lt; 250 presence dysfunctional organ system hematologic dysfunction : Platelet count &lt; 80.000/mm3 decrease 50 % 3 day precede enrollment ( absence liver cirrhosis previously know hematological disease ) metabolic dysfunction : In case unexplained metabolic acidosis pH &lt; 7,30 base deficit &gt; 5.0mmol/ litre association plasma lactate level &gt; 1,5 time upper normal limit SIRS : Patients meet least three follow four criterion : core temperature &gt; 38 &lt; 36Â°C heart rate &gt; 90 beat /min , except medical condition know increase heart rate respiratory rate &gt; 20 breaths/min PaCO2 &lt; 32mm Hg use mechanical ventilation acute respiratory process white cell count &gt; 12.000 cells/mm3 &lt; 4.000 cells/mm3 differential count show &gt; 10 % immature neutrophils Sepsis : Known suspected infection evidence one following : white cell bacteria normally sterile body fluid perforate viscus radiographic evidence pneumonia association production purulent sputum syndrome associate high risk infection The inclusion criterion meet time enrolment study , i.e . start baseline period . Patients follow condition exclude study : 1 . Age &lt; 18 year &gt; 80 year 2 . Weight &gt; 135 kg 3 . Pregnancy breastfeed 4 . Patients know absolute IgAdeficiency proven antibody formation IgA 5 . Patients know IVIGintolerability 6 . Patients know preexist neuromuscular disorder include . Patients document preexist severe polyneuropathy exclude . 7 . Patients know disease peripheral nerval system patient preexist disease central nerval system relevant impairment motor function . 8 . Patients relevant pulmonary edema secondary severe heart failure exclude relatively high infusion volume ( 5ml /kg body weight per day 3 day ) determine study medication 9 . Patients expect survive 28 day uncorrectable medical condition , poorly control neoplasma endstage disease 10 . Moribund state death perceive imminent 11 . HIV infection association last known CD4 count &lt; 50/mm3 12 . Prediction , base clinical judgement , patient require chronic ventilatory support nonrespiratory reason ( e.g . neuromuscular disease , paraplegia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Critical illness</keyword>
	<keyword>Critical illness polyneuropathy and/or myopathy</keyword>
	<keyword>Intravenous immunoglobulin</keyword>
	<keyword>Multiple organ failure</keyword>
	<keyword>SIRS</keyword>
	<keyword>Sepsis</keyword>
</DOC>